[Biomarkers for cancer immunotherapy].

Yutaka Kawakami, Yoshie Kawase, Azusa Ohizumi, Shinobu Noji, Toshiharu Sakurai, Tomonobu Fujita

研究成果: Review article査読

抄録

Immune-biomarkers and -assays are important for development of cancer immunotherapy to select the patients who are expected to respond to immunotherapy before or early after immunotherapy, to monitor immune induction following immunotherapy, and to evaluate anti-tumor effects early after immunotherapy. Comprehensive immune-evaluation including positive and negative immune responses against cancer cells and identification of blood biomarkers which reflect immune-conditions in tumor microenvironment are required although direct evaluation of tumor tissues can be possible for some patients. Importance of immune responses has recently been recognized even for standard cancer treatments including chemotherapy and molecular target therapy. Therefore, immunological biomarkers may be useful for any cancer treatment.

本文言語English
ページ(範囲)759-766
ページ数8
ジャーナルNihon rinsho. Japanese journal of clinical medicine
70
5
出版ステータスPublished - 2012 5

ASJC Scopus subject areas

  • Medicine(all)

フィンガープリント 「[Biomarkers for cancer immunotherapy].」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル